Fachinfo Comirnaty Omicron Xbb 1.5

Fachinfo Comirnaty Omicron Xbb 1.5. The us food and drug administration (fda) has approved pfizer and biontech’s supplemental biologics license application (sbla) for omicron xbb.1.5. The new covid variant, xbb.1.5, has quickly become the dominant strain in the us and has been identified in at least 37 other countries.

An overview of the comirnaty 30 (xbb.1.5). Ema’s human medicines committee (chmp) has recommended authorising an adapted comirnaty vaccine targeting the omicron xbb.1.5 subvariant.